In line with the stated strategy, the promoters of Aster DM Healthcare have successfully reduced their share pledge from 99% to 41% after completing a debt refinancing transaction from top-tier global financial institutions.

As part of the refinancing process, the new reputed lenders – JP Morgan, HSBC, and Barclays provided fresh funding, enabling Aster DM Healthcare promoters to refinance its existing loans at better terms as well as loan-to-value (LTV).

Dr. Azad Moopen, Founder and Chairman of Aster DM Healthcare, said, "The reduction in Aster’s pledged shares is a significant testament to our financial strength as promoters, especially in light of the volatile global market conditions. It reflects the strong confidence we have in our company’s growth trajectory, operational excellence, and strategic direction. This milestone also reinforces trust among our stakeholders, investors, and partners as we continue to expand our footprint in India.”